How Much Does Compounded Tirzepatide Cost? 2025 Pricing Guide
Compounded Tirzepatide Cost Snapshot
Monthly
Varies
Depends on provider and bundled support
Longer-term plans
Varies
Verify savings terms directly
Brand comparison
Case-by-case
Depends on current brand pricing
Verify current pricing directly before treating any comparison as a guaranteed savings outcome.
Understanding Tirzepatide Costs in 2025
Tirzepatide can be effective for many patients, but cost comparisons should be treated carefully because brand cash-pay pricing, compounded program pricing, and support models can change over time.
Compounded tirzepatide discussions are strongest when they explain what affects cost, what is bundled into the program, and how legitimacy and pharmacy route fit into the decision. This guide focuses on those comparison questions rather than promising a fixed savings figure.
Brand Name vs Compounded: Complete Cost Comparison
| Option | Monthly Cost | Annual Cost | Total Savings |
|---|---|---|---|
| Mounjaro (Brand) | Verify current brand pricing directly | Depends on current monthly pricing | - |
| Zepbound (Brand) | Verify current brand pricing directly | Depends on current monthly pricing | - |
| Compounded Tirzepatide | Varies by provider and program | Depends on the billing model | Depends on the current brand comparison |
What's Included in the Price?
Unlike brand-name options that often have hidden costs, reputable compounded tirzepatide providers typically include:
Trimi Health Pricing Tiers
Monthly Plan
$345
per month
- No commitment
- Cancel anytime
- Flexible dosing
6-Month Plan
$1,770
$295/month
Save $300 vs monthly
- Best value
- Consistent supply
- Priority support
Factors That Affect Compounded Tirzepatide Cost
1. Pharmacy Type (503A vs 503B)
503B facilities (outsourcing facilities) often have slightly higher costs due to increased FDA oversight, but this can mean better quality control.
Typical range: 503A: $250-$350 | 503B: $350-$450
2. Included Services
Providers offering comprehensive care (consultations, support, supplies) may charge more but provide better value.
3. Supply Chain & Raw Materials
Prices fluctuate based on availability of pharmaceutical-grade tirzepatide from FDA-registered suppliers.
4. Subscription Length
Longer commitments (3, 6, or 12 months) typically offer 15-25% savings vs month-to-month.
Is Compounded Tirzepatide Worth the Cost?
Expected Results & ROI
Average Weight Loss
20-25%
of body weight in 12 months
Monthly Cost Per Pound Lost
~$8-12
based on avg 25-30 lbs lost
When you consider the health benefits (reduced diabetes risk, improved cardiovascular health, better quality of life), many patients find compounded tirzepatide to be an excellent investment in their long-term health.
Hidden Costs to Watch Out For
When comparing prices, beware of providers that advertise low costs but add hidden fees:
- •Consultation fees: Some charge $99-$299 per consultation
- •Shipping costs: $15-$30 per shipment
- •Membership fees: Monthly platform fees
- •Supplies not included: Syringes sold separately
- •Price increases by dose: Higher doses cost more
💡 Trimi includes everything - no hidden fees, same price at any dose
Pricing FAQs
Does insurance cover compounded tirzepatide?
Generally no. Insurance typically only covers FDA-approved brand medications. However, the cash price for compounded is often lower than brand-name copays.
Can I use my HSA/FSA?
Yes! Compounded tirzepatide prescribed by a licensed provider is typically HSA/FSA eligible.
Do prices go up when my dose increases?
Not with Trimi. We charge the same price regardless of dose, from 2.5mg to 15mg.
Are there cheaper options online?
Beware of prices below $200/month - these are often from unverified sources or "research chemical" suppliers that are illegal and dangerous. Legitimate compounded tirzepatide from licensed pharmacies ranges $250-$450.
Related Articles
Related Reading
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.